ALPHARETTA, Ga.—
Clearside Biomedical, Inc., a biopharmaceutical company focused on the delivery of therapies to the back of the eye through the suprachoroidal space (SCS), has announced the appointment of Tony Gibney as chair of its board of directors, effective November 1, 2024.
Read more...